Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK1322322 vs Linezolid in ABSSSI
NCT01209078Phase 2Completed
- Sponsor
- GSK
- Start
- Aug 2010
- Primary completion
- Jan 2011
- Countries
- 1
01
Overview
A Phase 2 trial of lanopepden in acute bacterial skin and skin structure infection (ABSSSI), sponsored by GSK. Started Aug 2010; status: completed.
02
Drugs
lanopepden
03
Conditions
acute bacterial skin and skin structure infection (ABSSSI)
Beyond the preview
Go deeper on NCT01209078.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01209078.